Asset Management One Co. Ltd. decreased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 5.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 465,918 shares of the real estate investment trust's stock after selling 26,651 shares during the quarter. Asset Management One Co. Ltd. owned about 0.20% of Sabra Healthcare REIT worth $8,140,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in SBRA. VSM Wealth Advisory LLC acquired a new stake in shares of Sabra Healthcare REIT during the 4th quarter worth about $26,000. UMB Bank n.a. increased its position in shares of Sabra Healthcare REIT by 379.6% during the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after purchasing an additional 1,621 shares during the last quarter. Assetmark Inc. increased its position in shares of Sabra Healthcare REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after purchasing an additional 656 shares during the last quarter. Fifth Third Bancorp increased its position in shares of Sabra Healthcare REIT by 110.3% during the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock valued at $67,000 after acquiring an additional 2,011 shares during the last quarter. Finally, GF Fund Management CO. LTD. acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at about $74,000. Institutional investors and hedge funds own 99.40% of the company's stock.
Insider Buying and Selling
In related news, Director Michael J. Foster sold 11,000 shares of the business's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the transaction, the director now directly owns 64,725 shares of the company's stock, valued at $1,179,289.50. The trade was a 14.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.20% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on SBRA. Scotiabank lifted their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. Truist Financial lifted their target price on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the company a "hold" rating in a report on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT has a consensus rating of "Moderate Buy" and an average price target of $19.67.
Get Our Latest Stock Report on SBRA
Sabra Healthcare REIT Trading Down 1.2%
Shares of SBRA stock opened at $18.26 on Friday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.22 and a current ratio of 4.22. The stock has a market capitalization of $4.34 billion, a P/E ratio of 30.95, a price-to-earnings-growth ratio of 1.40 and a beta of 0.85. The company has a 50 day moving average price of $17.83 and a 200 day moving average price of $17.28. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.11 and a fifty-two week high of $20.03.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.01. The firm had revenue of $183.54 million during the quarter, compared to analysts' expectations of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The business's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.35 earnings per share. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Friday, May 16th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 annualized dividend and a yield of 6.57%. Sabra Healthcare REIT's payout ratio is 203.39%.
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Further Reading
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.